The new national cholesterol education program guidelines

被引:34
作者
Eidelman, RS [1 ]
Lamas, GA [1 ]
Hennekens, CH [1 ]
机构
[1] Mt Sinai Med Ctr, Miami Beach, FL 33140 USA
关键词
D O I
10.1001/archinte.162.18.2033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2033 / 2036
页数:4
相关论文
共 23 条
  • [1] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [2] Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians
    Bottorff, M
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) : 2273 - 2280
  • [3] DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION
    BURING, JE
    OCONNOR, GT
    GOLDHABER, SZ
    ROSNER, B
    HERBERT, PN
    BLUM, CB
    BRESLOW, JL
    HENNEKENS, CH
    [J]. CIRCULATION, 1992, 85 (01) : 22 - 29
  • [4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [5] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
    Downs, JR
    Clearfield, M
    Weis, S
    Whitney, E
    Shapiro, DR
    Beere, PA
    Langendorfer, A
    Stein, EA
    Kruyer, W
    Gotto, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
  • [6] Ducobu J, 2000, Rev Med Brux, V21, P11
  • [7] Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
    Fichtenbaum, CJ
    Gerber, JG
    Rosenkranz, SL
    Segal, Y
    Aberg, JA
    Blaschke, T
    Alston, B
    Fang, F
    Kosel, B
    Aweeka, F
    [J]. AIDS, 2002, 16 (04) : 569 - 577
  • [8] GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015
  • [9] Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials
    Hebert, PR
    Gaziano, JM
    Chan, KS
    Hennekens, CH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04): : 313 - 321
  • [10] Increasing burden of cardiovascular disease - Current knowledge and future directions for research on risk factors
    Hennekens, CH
    [J]. CIRCULATION, 1998, 97 (11) : 1095 - 1102